Italia markets closed

Teleflex Incorporated (TFX)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
206,710,00 (0,00%)
Alla chiusura: 04:00PM EDT
205,01 -1,70 (-0,82%)
Dopo ore: 04:03PM EDT

Teleflex Incorporated

550 East Swedesford Road
Suite 400
Wayne, PA 19087-1603
United States
610-225-6800
https://www.teleflex.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno14.500

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Liam J. KellyChairman, President & CEO2,63M5,44M1967
Mr. Thomas E. Powell BS, MBAExecutive VP & CFO1,29M1,39M1962
Mr. Daniel V. LogueCorporate VP, General Counsel & Secretary720,27kN/D1974
Mr. Jay WhiteCorporate VP & President of Global Commercial1,09MN/D1974
Mr. John R. DerenCorporate VP & Chief Accounting OfficerN/DN/DN/D
Mr. Timothy F. DuffyVP & Chief Information OfficerN/DN/DN/D
Mr. Howard CyrCorporate VP & Chief Compliance OfficerN/DN/DN/D
Mr. Cameron P. HicksCorporate Vice President of Human Resources & Communications564,68kN/D1965
Mr. James FergusonPresident & GM of SurgicalN/DN/DN/D
Ms. Michelle FoxCorporate VP & Chief Medical OfficerN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Governance aziendale

L'ISS Governance QualityScore di Teleflex Incorporated al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 9; diritti degli azionisti: 4; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.